Feng‐Pai Chou

735 total citations
19 papers, 581 citations indexed

About

Feng‐Pai Chou is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Feng‐Pai Chou has authored 19 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Hematology. Recurrent topics in Feng‐Pai Chou's work include Fibroblast Growth Factor Research (3 papers), Liver physiology and pathology (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Feng‐Pai Chou is often cited by papers focused on Fibroblast Growth Factor Research (3 papers), Liver physiology and pathology (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Feng‐Pai Chou collaborates with scholars based in Taiwan, United States and Japan. Feng‐Pai Chou's co-authors include Michael D. Johnson, Chen‐Yong Lin, Jehng-Kang Wang, Ya‐Wen Chen, Ming‐Shyue Lee, I‐Chu Tseng, Toni Antalis, Wei Huang, KyungMann Kim and Thomas C. Havighurst and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Feng‐Pai Chou

19 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng‐Pai Chou Taiwan 12 196 101 89 87 86 19 581
Jehng-Kang Wang Taiwan 18 295 1.5× 208 2.1× 157 1.8× 134 1.5× 142 1.7× 40 854
Shinji Kagaya Japan 9 227 1.2× 52 0.5× 148 1.7× 67 0.8× 40 0.5× 14 544
Tomas Bratt Denmark 11 372 1.9× 90 0.9× 166 1.9× 68 0.8× 71 0.8× 21 776
Kjetil Elvevold Norway 13 208 1.1× 60 0.6× 165 1.9× 87 1.0× 29 0.3× 24 800
Efraí­n Garrido Mexico 17 442 2.3× 154 1.5× 88 1.0× 173 2.0× 54 0.6× 48 716
Xing Gu China 17 621 3.2× 203 2.0× 187 2.1× 174 2.0× 19 0.2× 60 1.0k
Rocco Fraioli Italy 16 409 2.1× 45 0.4× 287 3.2× 263 3.0× 81 0.9× 28 977
Paulina Gronesova Slovakia 15 258 1.3× 149 1.5× 70 0.8× 199 2.3× 52 0.6× 38 601
Maureen E. Lane United States 15 307 1.6× 93 0.9× 45 0.5× 368 4.2× 40 0.5× 26 816

Countries citing papers authored by Feng‐Pai Chou

Since Specialization
Citations

This map shows the geographic impact of Feng‐Pai Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Pai Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Pai Chou more than expected).

Fields of papers citing papers by Feng‐Pai Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng‐Pai Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Pai Chou. The network helps show where Feng‐Pai Chou may publish in the future.

Co-authorship network of co-authors of Feng‐Pai Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Feng‐Pai Chou. A scholar is included among the top collaborators of Feng‐Pai Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng‐Pai Chou. Feng‐Pai Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Huê, Bùi Thị Bửu, Cường Quốc Nguyễn, Feng‐Pai Chou, et al.. (2024). Discovery of a novel benzimidazole conjugated quinazolinone derivative as a promising SARS-CoV-2 3CL protease inhibitor. RSC Advances. 14(46). 33820–33829. 5 indexed citations
2.
3.
Chou, Feng‐Pai, et al.. (2023). Quinazolinone-Peptido-Nitrophenyl-Derivatives as Potential Inhibitors of SARS-CoV-2 Main Protease. Viruses. 15(2). 287–287. 6 indexed citations
4.
5.
Chou, Feng‐Pai, et al.. (2022). Electroluminescence and photocatalytic hydrogen evolution of S,N co-doped graphene oxide quantum dots. Journal of Materials Chemistry A. 10(7). 3650–3658. 34 indexed citations
6.
Chen, Yi‐Ting, Feng‐Pai Chou, Chin‐Yuan Chang, et al.. (2021). Efficient and Reversible Catalysis of Formic Acid‐Carbon Dioxide Cycle Using Carbamate‐Substituted Ruthenium‐Dithiolate Complexes. ChemCatChem. 13(19). 4092–4098. 4 indexed citations
7.
Chou, Feng‐Pai, et al.. (2016). Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation. PLoS ONE. 11(4). e0152904–e0152904. 25 indexed citations
8.
Chou, Feng‐Pai, et al.. (2016). An enzymatic approach to configurationally rare trans‐androsteronyl‐α‐glucoside and Its potential anticancer application. Chemical Biology & Drug Design. 89(1). 61–66. 7 indexed citations
9.
Chou, Feng‐Pai, Han Xu, Ming‐Shyue Lee, et al.. (2011). Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells. American Journal of Physiology-Cell Physiology. 301(5). C1093–C1103. 5 indexed citations
10.
Xu, Han, Zhenghong Xu, I‐Chu Tseng, et al.. (2011). Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1. American Journal of Physiology-Cell Physiology. 302(2). C453–C462. 22 indexed citations
11.
Chen, Ya‐Wen, Ming‐Shyue Lee, Feng‐Pai Chou, et al.. (2010). TMPRSS2, a Serine Protease Expressed in the Prostate on the Apical Surface of Luminal Epithelial Cells and Released into Semen in Prostasomes, Is Misregulated in Prostate Cancer Cells. American Journal Of Pathology. 176(6). 2986–2996. 139 indexed citations
12.
Chen, Ya‐Wen, Jehng-Kang Wang, Feng‐Pai Chou, et al.. (2010). Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation. Journal of Biological Chemistry. 285(41). 31755–31762. 59 indexed citations
13.
Chen, Cheng‐Jueng, Mei-Hsuan Wu, Herng‐Sheng Lee, et al.. (2010). Increased matriptase zymogen activation in inflammatory skin disorders. American Journal of Physiology-Cell Physiology. 300(3). C406–C415. 36 indexed citations
14.
Tseng, I‐Chu, Han Xu, Feng‐Pai Chou, et al.. (2009). Matriptase Activation, an Early Cellular Response to Acidosis. Journal of Biological Chemistry. 285(5). 3261–3270. 63 indexed citations
15.
Wang, Jehng-Kang, Ming‐Shyue Lee, I‐Chu Tseng, et al.. (2009). Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. American Journal of Physiology-Cell Physiology. 297(2). C459–C470. 60 indexed citations
16.
Tseng, I‐Chu, Feng‐Pai Chou, Sheng‐Fang Su, et al.. (2008). Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. American Journal of Physiology-Cell Physiology. 295(2). C423–C431. 32 indexed citations
17.
Simbulan‐Rosenthal, Cynthia M., et al.. (2005). Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation. Oncogene. 24(35). 5443–5458. 18 indexed citations
18.
Rosenthal, Dean S., Alfredo Velena, Feng‐Pai Chou, et al.. (2003). Expression of Dominant-negative Fas-associated Death Domain Blocks Human Keratinocyte Apoptosis and Vesication Induced by Sulfur Mustard. Journal of Biological Chemistry. 278(10). 8531–8540. 50 indexed citations
19.
Chen, Hsiang‐Wen, et al.. (1999). EVIDENCE OF MULTI-STEP REGULATION OF HSP72 EXPRESSION IN EXPERIMENTAL SEPSIS. Shock. 12(1). 63–68. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026